GSRRX
Price
$11.05
Change
-$0.01 (-0.09%)
Updated
Jun 20 closing price
Net Assets
428.43M
VIVAX
Price
$67.64
Change
+$0.12 (+0.18%)
Updated
Jun 20 closing price
Net Assets
188.77B
Interact to see
Advertisement

GSRRX vs VIVAX

Header iconGSRRX vs VIVAX Comparison
Open Charts GSRRX vs VIVAXBanner chart's image
Goldman Sachs Rising Dividend Gr R
Price$11.05
Change-$0.01 (-0.09%)
VolumeN/A
Net Assets428.43M
Vanguard Value Index I
Price$67.64
Change+$0.12 (+0.18%)
VolumeN/A
Net Assets188.77B
GSRRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSRRX vs. VIVAX commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. GSRRX (428M). VIVAX pays higher dividends than GSRRX: VIVAX (2.16) vs GSRRX (1.28). GSRRX was incepted earlier than VIVAX: GSRRX (13 years) vs VIVAX (33 years). GSRRX (1.52) is less costly to investors than VIVAX (0.17). GSRRX is a more actively managed with annual turnover of: 42.00 vs. VIVAX (9.00). GSRRX has a lower initial minimum investment than VIVAX: GSRRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.74 vs. GSRRX (-8.05). VIVAX return over 5 years is better than : 70.82 vs. GSRRX (27.39).
GSRRXVIVAXGSRRX / VIVAX
Total Expense Ratio1.260.17741%
Annual Report Gross Expense Ratio1.520.17894%
Fund Existence13 years33 years-
Gain YTD0.4832.23722%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets428M189B0%
Annual Yield % from dividends1.282.1659%
Returns for 1 year-8.056.74-119%
Returns for 3 years7.7532.2224%
Returns for 5 years27.3970.8239%
Returns for 10 years-40.88102.09-40%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVID0.310.02
+5.24%
Ovid Therapeutics
TPH30.530.64
+2.14%
Tri Pointe Homes
ULTA473.850.39
+0.08%
Ulta Beauty
OBK34.08-0.59
-1.70%
Origin Bancorp
DSGN3.72-0.07
-1.85%
Design Therapeutics